News and features

Research is enabling scientists to anticipate how different cancers evolve in the body, opening up the possibility of being able to predict how cancers change with time.

Researchers have identified a protein that controls how breast cancer cells spread around the body, according to a new study.

In a special, three-part essay to mark World Cancer Day, ICR Chief Executive Professor Paul Workman reflects on five decades of advances in cancer treatment – inspired by The Death of Cancer, an account by early pioneer Vincent DeVita. In part one, Professor Workman discusses the early days of chemotherapy.

On World Cancer Day, we wanted to recognise our many global collaborators who work with us to make the discoveries that defeat cancer.

A new global hub for cancer research and treatment is to be established in London with the aim of accelerating the discovery of new treatments.

The Institute of Cancer Research, London, has sold a portion of its royalty entitlement for the prostate cancer drug abiraterone for an undisclosed sum.

Combining a chemotherapy drug with first-line hormone therapy could help men diagnosed with prostate cancer live longer, according to research.

Scientists have identified a change in the DNA of patients with myeloma that increases their risk of developing bone disease, a common and serious complication of this cancer.

Scientists from The Institute of Cancer Research, London, gave two talks at this exciting conference that ran from 19-21 January 2016. See some of the reaction to the presentations.

Cancers evolve over time in patterns governed by the same natural laws that drive physical and chemical processes as diverse as the flow of rivers or the brightness of stars, according to new research.

Wnt7a protein found to be key "rallying call" secreted by aggressive tumours to help recruit non-cancerous fibroblasts and enable growth.

Donors and supporters of The Institute of Cancer Research, London, contributed £12.3 million in charitable donations in 2015.